Given the fact that 16- to 29-year-old males showed a higher incidence of COVID-19 vaccine-related myocarditis than other groups, we speculate that young men could have a stronger IL-18 production and Th1 immune response compared to females, although this requires further investigation (3). The gene discussed is IL18; the disease is COVID-19.